Yale report: Millions of people with hepatitis C blocked from obtaining treatment in low-and middle-income countries
Just last week, worldwide leaders came together in Geneva, Switzerland at the World Health Organization to begin to develop a five-year strategy to combat Hepatitis C.
Statin use associated with reduced risk of liver cancer among those in the UK
In a nested-case control study of individuals living in the UK, a part of the world with a relatively low incidence of liver cancer, statin use is associated with a decreased risk of liver cancer...
Plant chemicals may prevent liver damage caused by fat accumulated during menopause
Women going through menopause often struggle with weight gain that results when their estrogen levels drop, and many turn to weight-loss supplements to help them shed those extra pounds.
Stellate cells in the liver control regeneration and fibrosis
Liver fibrosis, which is the progressive formation of scar tissue in the liver, is a massive medical problem.
Two studies show promising results in treating hepatitis C in patients co-infected with HIV
With there being a need for interferon-free treatment because of potential toxicities for patients with hepatitis C virus (HCV) and human immunodeficiency virus 1 (HIV-1), two studies appearing in...
Small molecule might help reduce cancer in at-risk population, Stanford study finds
Researchers at the Stanford University School of Medicine have found that by changing the selectivity of an enzyme, a small molecule could potentially be used to decrease the likelihood of...
Alcohol places Hispanics at a much greater risk of developing alcoholic liver disease
Alcoholic liver disease (ALD) refers to a broad spectrum of liver injuries, including alcoholic fatty liver, alcoholic hepatitis, and alcoholic cirrhosis.
UAlberta researchers wind up a 40-year-old debate on betaretrovirus infection in humans
Exploring a viral connection to primary biliary cirrhosisIn a new study published in Alimentary Pharmacology & Therapeutics, researchers at the University of Alberta's Faculty of Medicine ...
amfAR report examines controversial pricing of hepatitis C treatment
Despite important price reductions for some low- and middle-income countries, the exorbitant drug pricing of breakthrough treatments for hepatitis C (HCV) infection will inevitably limit access to...
Study demonstrates significant survival benefit in patients treated with once-daily Advagraf over standard of care in liver transplantation
Results of a large observational study published in the American Journal of Transplantation (AJT) has demonstrated that early and sustained use of Advagraf, a once-daily immunosuppressant, offers a...